A Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid Tumors
AbbVie
AbbVie
AstraZeneca
Innovent Biologics (Suzhou) Co. Ltd.
Merck Sharp & Dohme LLC
Takeda
Oncology Institute of Southern Switzerland
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Samsung Medical Center
GlaxoSmithKline